Original ResearchFull Report: Clinical—Alimentary TractIdentification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome
Keywords
Abbreviations used in this paper
Cited by (0)
Conflicts of interest These authors disclose the following: Boris Le Nevé, Muriel Derrien, Rémi Brazeilles, Stéphanie Cools-Portier, and Julien Tap are employees of Danone Research; Muriel Simrén has received unrestricted research grants from Danone and AstraZeneca, and has served as a consultant/advisory board member for AstraZeneca, Danone, Novartis, Almirall, Albiroe, Shire, Nestlé, Glycom, and Chr Hansen, and has served on the speaker’s bureau for Takeda, Tillotts, Shire, Almirall, Menarini, and Danone; Lena Öhman has received financial support for research from Danone Research, has served as a consultant for Genetic Analyses, and has received lecture fees from AbbVie and Takeda; Joël Doré has received financial support for research from Danone Research, Pfizer, and PiLeJe, and has served as a consultant/advisory board member for Danone Research, AlphaWasserman, Enterome Bioscience, and MaaT Pharma; and Hans Törnblom has served as a consultant/advisory board member for Almirall, Allergan, Danone, and Shire, and has been on the speakers’ bureau for Tillotts, Takeda, Shire, and Almirall. The remaining author discloses no conflicts.
Funding This research was supported by the Swedish Medical Research Council (grants 13409, 21691, and 21692), AFA (Arbetsmarknadens Försäkringsaktiebolag) Insurance, The Marianne and Marcus Wallenberg Foundation, Centre for Person-Centered Care, Sahlgrenska Academy, University of Gothenburg, the Faculty of Medicine at the University of Gothenburg, VINNOVA, as well as by Danone Nutricia Research.
- ∗
Authors share co-first authorship
- §
Authors share co-senior authorship.